23 magg 2017 anni - Pembrolizumab Approved
Descrizione:
FDA approved Pembrolizumab for specific tumors which have been identified to have a biomarker referred to as microsatellite instability-high. Meant for those who have undergone other treatments, and with no other alternatives.
Aggiunto al nastro di tempo:
Data:
~ 8 years and 4 months ago